DNAJC24

Across TCGA pan-cancer cohorts, DNAJC24 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DNAJC24 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher DNAJC24 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated DNAJC24 expression acts as an unfavorable survival marker.

CCRCC, PDAC, and LSCC are the cancer types where DNAJC24 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	All	0.780	0.953	<.001	8	view →
PDAC	OS	Tertile	All	0.814	1.000	.020	5	view →
LSCC	OS	Tertile	All	0.607	1.000	.027	4	view →
LUAD	OS	Median	II,III,IV	0.317	0.686	.036	4	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

DNAJC24–CCRCC (OS)

Open the CCRCC breakdown →